0001753926-24-000573.txt : 20240319
0001753926-24-000573.hdr.sgml : 20240319
20240319182108
ACCESSION NUMBER: 0001753926-24-000573
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240315
FILED AS OF DATE: 20240319
DATE AS OF CHANGE: 20240319
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kaufman Jonathan H
CENTRAL INDEX KEY: 0001959250
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41575
FILM NUMBER: 24765485
MAIL ADDRESS:
STREET 1: C/O LIPELLA PHARMACEUTICALS INC.
STREET 2: 7800 SUSQUEHANNA ST., SUITE 505
CITY: PITTSBURGH
STATE: PA
ZIP: 15208
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LIPELLA PHARMACEUTICALS INC.
CENTRAL INDEX KEY: 0001347242
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 N LEXINGTON ST
STREET 2: STE LL103
CITY: PITTSBURGH
STATE: PA
ZIP: 15208
BUSINESS PHONE: 412-901-0315
MAIL ADDRESS:
STREET 1: 400 N LEXINGTON ST
STREET 2: STE LL103
CITY: PITTSBURGH
STATE: PA
ZIP: 15208
FORMER COMPANY:
FORMER CONFORMED NAME: LIPELLA PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20051219
4
1
ownership.xml
FORM 4
X0508
4
2024-03-15
0
0001347242
LIPELLA PHARMACEUTICALS INC.
LIPO
0001959250
Kaufman Jonathan H
C/O LIPELLA PHARMACEUTICALS INC.
7800 SUSQUEHANNA ST., SUITE 505
PITTSBURGH
PA
15208
1
1
1
0
See remarks below.
0
Common Stock
2024-03-18
4
P
0
30000
0.7883
A
863849
D
Common Stock
2024-03-19
4
P
0
25000
0.8721
A
888849
D
Stock Options
0.77
2024-03-15
4
A
0
80000
0
A
2024-03-15
2034-03-15
Common Stock
80000
80000
D
Open market purchase by the reporting person of 30,000 shares of common stock, par value $0.0001 per share (the "Common Stock").
Reflects the weighted average price of the shares purchased on the open market in multiple transactions on March 18, 2024 at prices ranging from $0.77 to $0.80 per share, inclusive.
The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of such shares of Common Stock purchased at each separate price within such range.
Open market purchase by the reporting person of 25,000 shares of Common Stock.
Reflects the weighted average price of the shares of Common Stock purchased on the open market in multiple transactions on March 19, 2024 at prices ranging from $0.75 to $0.89 per share, inclusive.
President, Chief Executive Officer, Secretary, Treasurer, and Chairman of the Board of Directors
/s/ Jonathan H. Kaufman
2024-03-19